✦ LIBER ✦

Cancer rejection by the immune system: Forcing the check-points of tumor immune escape

✍ Scribed by Simone Mocellin; Susanna Mandruzzato; Paola Zanovello; Vincenzo Bronte

Book ID: 119225345
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 240 KB
Volume: 2
Category: Article
ISSN: 1740-6765
DOI: 10.1016/j.ddmec.2005.05.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor immune escape mechanisms: impact o

Tumor immune escape mechanisms: impact of the neuroendocrine system

✍ Kerstin Lang; Frank Entschladen; Corinna Weidt; Kurt S. Zaenker 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 454 KB

Cellular Constituents of Immune Escape w

Cellular Constituents of Immune Escape within the Tumor Microenvironment

✍ Kerkar, S. P.; Restifo, N. P. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 778 KB

The role of chemokines in cancer immune

The role of chemokines in cancer immune surveillance by the adaptive immune system

✍ Carsten Krieg; Onur Boyman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 382 KB

No cancer in cancers: Evolutionary trade

No cancer in cancers: Evolutionary trade-off between successful viviparity and tumor escape from the adaptive immune system

✍ Satoshi Hayakawa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 270 KB

228 Anti-tumor Efficacy with a Novel Pep

228 Anti-tumor Efficacy with a Novel Peptide Inhibitor of the PD-1 Immune Check Point Pathway

✍ Ramachandra, M.; Sasikumar, P.G.; Satyam, L.K.; Shrimali, R.K.; Subbarao, K.; Ra 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Immune manipulation of advanced breast c

Immune manipulation of advanced breast cancer: An interpretative model of the relationship between immune system and tumor cell biology

✍ Andrea Nicolini; Angelo Carpi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

## Abstract This review summarizes some recent clinical immunological approaches with cytokines and/or antibodies for therapy of advanced breast cancer. It considers the recent advances in genetics and molecular tumor biology related to impaired immunosurveillance involving cytokines and growth fac